Martnez Alvarez, Jess Romn, et al
The higher the dose of the GLP-1 agonist, the more extreme the effects
The manufacturer did this after completing a 64-week OASIS 4 phase 3 trial
As recent studies show the amount of people taking glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss, and not for managing type 2 diabetes as originally used, researchers have been examining these medications for potential positive and negative side effects
Lyn called me the morning after a visit and, because she had taken the time to peruse my file the evening after I left her office, she notified me that an upcoming surgery I had scheduled must be delayed due to a medication she had prescribed during my visit
The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction